Pedro J. Castro

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 157 publications

The clinical picture of ICANS after CAR-T cell therapy in critically ill patients: A retrospective clustering analysis of a multicentre multinational cohort study.

The clinical picture of ICANS after CAR-T cell therapy in critically ill patients: A retrospective clustering analysis of a multicentre multinational cohort study.

Journal: Annals of intensive care

Published: May 08, 2026

Use of the TALK Tool for Interprofessional Team Self-Debrief During Everyday Opportunities for Learning in Critical Care.

Use of the TALK Tool for Interprofessional Team Self-Debrief During Everyday Opportunities for Learning in Critical Care.

Journal: American journal of critical care : an official publication, American Association of Critical-Care Nurses

Published: April 30, 2026

Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy.

Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy.

Journal: Open forum infectious diseases

Published: March 31, 2026

Assessment of the risk of bacteremia in patients with hematologic malignancies in the emergency department: A comparative study between logistic regression and machine learning algorithms.

Assessment of the risk of bacteremia in patients with hematologic malignancies in the emergency department: A comparative study between logistic regression and machine learning algorithms.

Journal: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias

Published: March 25, 2026

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

Journal: European journal of haematology

Published: February 26, 2026

Impact of extracorporeal membrane oxygenation on antimicrobial exposure in critically ill patients: a prospective observational study.

Impact of extracorporeal membrane oxygenation on antimicrobial exposure in critically ill patients: a prospective observational study.

Journal: Critical care (London, England)

Published: February 25, 2026

Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.

Mesenchymal stromal cell-based therapy in the COVID-19 pandemic: results from an academic phase I/II double-blind, randomized, placebo-controlled clinical trial and reflections for the field.

Journal: Cytotherapy

Published: February 18, 2026

Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenators.

Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenators.

Journal: Heart & lung : the journal of critical care

Published: February 16, 2026

Increased circulating ACE2 and GAS6 are independent predictors of COVID-19 severity.

Increased circulating ACE2 and GAS6 are independent predictors of COVID-19 severity.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 12, 2026

Increased circulating ACE2 and GAS6 are independent predictors of COVID-19 severity.

Increased circulating ACE2 and GAS6 are independent predictors of COVID-19 severity.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 12, 2026

In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19.

In Vitro Evidence of Therapy-Induced Suppression of Prothrombotic and Proinflammatory Phenotypes in Severe COVID-19.

Journal: Thrombosis and haemostasis

Published: January 23, 2026

Case Report: Thymoma-associated myasthenia gravis, myositis, myocarditis, and anti-GAD65 autoimmune encephalitis: a unique case of paraneoplastic polyautoimmunity.

Case Report: Thymoma-associated myasthenia gravis, myositis, myocarditis, and anti-GAD65 autoimmune encephalitis: a unique case of paraneoplastic polyautoimmunity.

Journal: Frontiers in immunology

Published: December 08, 2025

Showing 1-12 of 157

Last Updated: 09/26/2026